These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 16988446)
21. DNA vaccination against tumors. Prud'homme GJ J Gene Med; 2005 Jan; 7(1):3-17. PubMed ID: 15538731 [TBL] [Abstract][Full Text] [Related]
22. Immunology of DNA vaccines: CpG motifs and antigen presentation. Manders P; Thomas R Inflamm Res; 2000 May; 49(5):199-205. PubMed ID: 10893042 [TBL] [Abstract][Full Text] [Related]
23. A novel bi-functional DNA vaccine expressing VP1 protein and producing antisense RNA targeted to 5'UTR of foot-and-mouth disease virus can induce both rapid inhibitory effect and specific immune response in mice. Yang B; Lan X; Li X; Yin X; Li B; Han X; Li Y; Zhang Z; Liu J Vaccine; 2008 Oct; 26(43):5477-83. PubMed ID: 18694793 [TBL] [Abstract][Full Text] [Related]
24. Adjuvant effects of plasmid-generated hairpin RNA molecules on DNA vaccination. Li D; Liu Y; Zhang Y; Xu J; Hong K; Sun M; Shao Y Vaccine; 2007 Sep; 25(39-40):6992-7000. PubMed ID: 17716788 [TBL] [Abstract][Full Text] [Related]
25. Plasmidic CpG sequences induce tumor microenvironment modifications in a rat liver metastasis model. Bertin S; Anjuere F; Gavelli A; Baque P; Soilihi BK; Brossette N; Loubat A; Pierrefite-Carle V Int J Mol Med; 2008 Mar; 21(3):309-15. PubMed ID: 18288378 [TBL] [Abstract][Full Text] [Related]
26. Construction of a recombinant plasmid containing multi-copy CpG motifs and its effects on the innate immune responses of aquatic animals. Chen Y; Xiang LX; Shao JZ Fish Shellfish Immunol; 2007 Sep; 23(3):589-600. PubMed ID: 17475508 [TBL] [Abstract][Full Text] [Related]
27. CpG motifs are efficient adjuvants for DNA cancer vaccines. Schneeberger A; Wagner C; Zemann A; Lührs P; Kutil R; Goos M; Stingl G; Wagner SN J Invest Dermatol; 2004 Aug; 123(2):371-9. PubMed ID: 15245438 [TBL] [Abstract][Full Text] [Related]
28. Reducing the immunostimulatory activity of CpG-containing plasmid DNA vectors for non-viral gene therapy. Yew NS; Cheng SH Expert Opin Drug Deliv; 2004 Nov; 1(1):115-25. PubMed ID: 16296724 [TBL] [Abstract][Full Text] [Related]
29. HIV-1 DNA vaccine efficacy is enhanced by coadministration with plasmid encoding IFN-alpha. Jiang W; Ren L; Jin N J Virol Methods; 2007 Dec; 146(1-2):266-73. PubMed ID: 17868910 [TBL] [Abstract][Full Text] [Related]
30. CpG methylation of a plasmid vector results in extended transgene product expression by circumventing induction of immune responses. Reyes-Sandoval A; Ertl HC Mol Ther; 2004 Feb; 9(2):249-61. PubMed ID: 14759809 [TBL] [Abstract][Full Text] [Related]
31. In vitro and in vivo evaluation of intrinsic immunogenicity of reporter and insulin gene therapy plasmids. Ratanamart J; Huggins CG; Kirby JA; Shaw JA J Gene Med; 2007 Aug; 9(8):703-14. PubMed ID: 17595049 [TBL] [Abstract][Full Text] [Related]
39. TLR9 as a key receptor for the recognition of DNA. Kumagai Y; Takeuchi O; Akira S Adv Drug Deliv Rev; 2008 Apr; 60(7):795-804. PubMed ID: 18262306 [TBL] [Abstract][Full Text] [Related]
40. Linear doggybone DNA vaccine induces similar immunological responses to conventional plasmid DNA independently of immune recognition by TLR9 in a pre-clinical model. Allen A; Wang C; Caproni LJ; Sugiyarto G; Harden E; Douglas LR; Duriez PJ; Karbowniczek K; Extance J; Rothwell PJ; Orefo I; Tite JP; Stevenson FK; Ottensmeier CH; Savelyeva N Cancer Immunol Immunother; 2018 Apr; 67(4):627-638. PubMed ID: 29330557 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]